BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 224,800 shares, a growth of 19.0% from the June 30th total of 188,900 shares. Based on an average trading volume of 160,500 shares, the short-interest ratio is presently 1.4 days. Approximately 2.9% of the shares of the company are sold short.
BioNexus Gene Lab Stock Performance
Shares of BGLC traded down $0.02 during trading hours on Friday, hitting $0.49. The stock had a trading volume of 51,409 shares, compared to its average volume of 122,678. BioNexus Gene Lab has a 12 month low of $0.31 and a 12 month high of $3.87. The stock has a fifty day moving average price of $0.49 and a 200 day moving average price of $0.60.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. BioNexus Gene Lab had a negative return on equity of 30.74% and a negative net margin of 27.24%. The firm had revenue of $2.38 million during the quarter.
Institutional Trading of BioNexus Gene Lab
BioNexus Gene Lab Company Profile
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Featured Articles
- Five stocks we like better than BioNexus Gene Lab
- What is a Special Dividend?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- What Are Dividend Challengers?
- Why Call Options Volume for These 2 Stocks Spiked Together
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.